01 3Allergan Inc.
02 42Gowling Strathy & Henderson
03 15Blank
01 101308656
02 101332150
03 11335566
04 91338775
05 52009533
06 92072509
07 62108018
08 42132933
09 12190485
10 42302963
11 12309033
01 45Cyclosporine
02 15Blank
01 33Capsule
02 2Injectable Ampuls
03 3Ophthalmic Emulsion
04 7Oral Solution
05 15Blank
01 102009-10-13
02 52010-02-07
03 102011-09-27
04 62012-04-16
05 12012-05-15
06 92012-06-26
07 92013-12-10
08 82014-09-26
09 22015-05-17
Patent Expiration Date : 2015-05-17
Date Granted : 2003-08-26
Brand Name : RESTASIS
Patent Number : 2309033
Filing Date : 1995-05-17
Strength per Unit : 0.05%
Dosage Form : Ophthalmic Emulsion
Human Or VET : Human
Route of Administration : Topical Opthalmic
Patent Expiration Date : 2015-05-17
Date Granted : 2003-08-26
Patent Expiration Date : 2015-05-17
Date Granted : 2003-04-15
Brand Name : RESTASIS
Patent Number : 2190485
Filing Date : 1995-05-17
Strength per Unit : 0.05%
Dosage Form : Ophthalmic Emulsion
Human Or VET : Human
Route of Administration : Topical Opthalmic
Patent Expiration Date : 2015-05-17
Date Granted : 2003-04-15
Patent Expiration Date : 2012-05-15
Date Granted : 1995-05-16
Brand Name : RESTASIS
Patent Number : 1335566
Filing Date : 1989-04-19
Strength per Unit : 0.05%
Dosage Form : Ophthalmic Emulsion
Human Or VET : Human
Route of Administration : Topical Opthalmic
Patent Expiration Date : 2012-05-15
Date Granted : 1995-05-16
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Brand Name : SANDIMMUNE
Patent Number : 2108018
Filing Date : 1992-04-16
Strength per Unit : unit = 1 ml 50 mg
Dosage Form : Injectable Ampuls
Human Or VET : Human
Route of Administration : injectable
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Brand Name : NEORAL
Patent Number : 2108018
Filing Date : 1992-04-16
Strength per Unit : 50 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Patent Expiration Date : 2014-09-26
Date Granted : 2001-10-23
Brand Name : NEORAL
Patent Number : 2302963
Filing Date : 1994-09-26
Strength per Unit : 50 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-09-26
Date Granted : 2001-10-23
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Brand Name : NEORAL
Patent Number : 2108018
Filing Date : 1992-04-16
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Patent Expiration Date : 2014-09-26
Date Granted : 2001-10-23
Brand Name : NEORAL
Patent Number : 2302963
Filing Date : 1994-09-26
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-09-26
Date Granted : 2001-10-23
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Brand Name : NEORAL
Patent Number : 2108018
Filing Date : 1992-04-16
Strength per Unit : 25 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Patent Expiration Date : 2014-09-26
Date Granted : 2001-10-23
Brand Name : NEORAL
Patent Number : 2302963
Filing Date : 1994-09-26
Strength per Unit : 25 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-09-26
Date Granted : 2001-10-23
LOOKING FOR A SUPPLIER?
